A Win For Alterity Therapeutics Limited
Alterity Therapeutics Limited (ATHE:NASDAQ) rocketted at $2.02, a gain of 27.8%. The stock got featured on our News Catalysts scanner on Thu, Jul 01, 2021 at 04:43 PM in the 'ACQUISITION' category. From Wed, Jun 23, 2021, the stock recorded 33.33% Up Days and 50.00% Green Days
The stock spiked on Thu, Jul 01, 2021 at $2.75 with a volume of 252M+.
About Alterity Therapeutics Limited (ATHE:NASDAQ)
Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.
Top 10 Gainers:
- Carver Bancorp, Inc. (CARV:NASDAQ), 106.9%
- Nova LifeStyle, Inc. (NVFY:NASDAQ), 71.5%
- UTME (UTME:NASDAQ), 43.11%
- CRTD (CRTD:NASDAQ), 39.1%
- Cohen & Company Inc. (COHN:NYSEMKT), 36.41%
- GBS (GBS:NASDAQ), 33.22%
- Alterity Therapeutics Limited (ATHE:NASDAQ), 27.85%
- Calyxt, Inc. (CLXT:NASDAQ), 26.05%
- Xtant Medical Holdings, Inc. (XTNT:NYSEMKT), 23.33%
- Verb Technology Company, Inc. (VERB:NASDAQ), 20.67%